US Patent:
20070010423, Jan 11, 2007
Inventors:
Karsten Wassermann - Belle Mead NJ, US
Erik Wulff - Birkerod, DK
International Classification:
A61K 38/28
A61K 31/4439
A61K 31/426
A61K 31/401
A61K 31/366
A61K 31/22
A61K 31/155
US Classification:
514003000, 514342000, 514369000, 514594000, 514423000, 514460000, 514548000, 514635000
Abstract:
Methods for the treatment of type 2 diabetes and related conditions comprising the admini-stration of balaglitazone in combination with one or more other antidiabetic compound is pro-vided together with combinations useful in said treatment.